As the perimenopause movement rises: awareness, or a commercial opportunity?
Perimenopause — the transition toward menopause — has become markedly more visible in public conversation in recent years. In an opinion piece published by STAT News, two experts examine the commercial ecosystem that this growing awareness has brought with it.
In the assessment the authors set out in STAT News, 'a whole industry seems to have sprung up' around the topic. The phrasing points to perimenopause having become not only a health matter but also a growing market.
The authors stress that the rise in awareness is in itself a positive development. Making visible symptoms that were under-discussed for a long time helps many women name their experience and seek support.
The piece, however, draws attention to another side of that visibility. Supplement and hormone claims that are not sufficiently backed by scientific evidence, spread through social-media influencers and some product marketers, carry the risk of misleading women.
In the authors' framing in STAT News, the core problem is the blurring of the line between genuine medical need and marketing promises. While the variety of symptoms means there is no single solution that fits everyone, some promotions can reduce that complexity to simple product recommendations.
Hormone-based claims form a sensitive part of this debate. The piece acknowledges that hormone therapy can be a legitimate option in some cases, while noting that general promises offered without individual assessment can be misleading.
The supplement market is known as an area where regulation is looser than for medicines. That situation creates conditions in which products whose efficacy and safety have not been independently verified can be marketed relatively easily — a point the authors underline.
A balanced view is preserved in the piece: the aim is not to dismiss the perimenopause movement entirely, but to distinguish those who benefit from it from those who profit commercially from it. Preserving the gains brought by awareness while limiting misinformation is the central goal the authors set out.
Access to evidence-based information in women's health sits at the centre of this debate. Turning to reliable sources, assessing symptoms with a health professional, and approaching general promises with caution are among the practical emphases highlighted in the piece.
This article is a health opinion text and is not a substitute for individual medical advice. People experiencing perimenopause symptoms are advised to weigh decisions about supplement or hormone use together with a qualified health professional.